Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Episode 7 - Benefits of Diabetes Educator Referrals

Episode 7 - Benefits of Diabetes Educator Referrals

FromKnow Diabetes by Heart™ Professional Education Podcast Series


Episode 7 - Benefits of Diabetes Educator Referrals

FromKnow Diabetes by Heart™ Professional Education Podcast Series

ratings:
Length:
31 minutes
Released:
Jun 21, 2019
Format:
Podcast episode

Description

Diabetes education has positive effects not only on psychosocial and behavioral aspects of diabetes care, but also known to be a cost-effective treatment by reducing hospital readmissions and lowered risk for complications. Yet, many patients often do not receive DSMES (Diabetes Self-Management Education and Support) referrals. Listen to Nancy D’Hondt, a certified diabetes educator and registered pharmacist, Dr. Lillian Khor, a cardiologist and Dr. Jay Shubrook, an osteopathic family physician, discuss how they work with CDEs and the benefits found from referring patients to diabetes self-management programs and a certified diabetes educator.
Released:
Jun 21, 2019
Format:
Podcast episode

Titles in the series (33)

The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The American Heart Association’s and the American Diabetes Association's Know Diabetes by Heart Professional Education™ Podcast Series is brought to you by founding sponsors, Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance and Novo Nordisk, and national sponsors, Sanofi, AstraZeneca, and Bayer.